林 毓志

Medicine & Life Sciences

1. Premature Infants 100%
2. Very Low Birth Weight Infant 53%
3. Dexamethasone 48%
4. Newborn Infant 31%
5. Bronchopulmonary Dysplasia 21%
6. Gestational Age 20%
7. Patent Ductus Arteriosus 19%
8. Lung Diseases 17%
9. Birth Weight 16%
10. Respiratory Distress Syndrome In Premature Infants 16%
11. Parturition 15%
12. Neonatal Intensive Care Units 15%
13. Machine Learning 15%
14. Mortality 15%
15. Lung 14%
16. Retinopathy of Prematurity 14%
17. Newborn Respiratory Distress Syndrome 14%
18. Extremely Low Birth Weight Infant 13%
19. Secondary Prevention 13%
20. Pneumonia 13%
21. Hospitalization 13%
22. Chronic Disease 11%
23. Therapeutics 11%
24. Artificial Respiration 11%
25. Hypoglycemia 10%
26. Respiratory Syncytial Viruses 9%
27. Morbidity 9%
28. Growth 9%
29. Pulmonary Hypertension 9%
30. Incidence 9%
31. Bilirubin 9%
32. Body Weight 8%
33. Multicenter Studies 8%
34. Nitric Oxide 7%
35. Branchioma 7%
36. Palivizumab 7%
37. Congenital Hyperinsulinism 7%
38. Length of Stay 7%
39. Cohort Studies 6%
40. Meconium Aspiration Syndrome 6%
41. Ebstein Anomaly 6%
42. Pulmonary Surfactant-Associated Protein D 6%
43. Randomized Controlled Trials 6%